Advertisement

Topics

Athera Biotechnologies & ALPCO Company Profile

04:04 EST 24th November 2017 | BioPortfolio

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two biopharmaceutical product candidates aimed at treating patients with acute heart conditions and a biomarker linked to the therapeutic approach. Athera is a Karolinska Development AB (publ) portfolio company and is also a major partner in the highly ranked EU-project CVDIMMUNE, which also includes Karolinska Institute, Imperial College London, Phadia GmbH and TNO.


News Articles [97 Associated News Articles listed on BioPortfolio]

Athera Biotechnologies Initiates Phase IIa Trial On Arterial Inflammation With Its Antibody PC-mAb

Athera initiates Phase 2a trial on arterial inflammation with its antibody PC-mAb Stockholm October 11, 2017 Athera Biotechnologies AB today announced that screening has started for a Phase 2a prospec...

Athera Biotechnologies Allowed US Composition Of Matter Patents For Therapeutic Antibodies

  Life Sciences Jobs   ...

Athera Biotechnologies Completes Financing To Advance Clinic With Immunovascular Antibody

  Life Sciences Jobs   ...

Athera Biotechnologies Completes Financing To Advance Clinic With Immunovascular Antibody Aug 29, 2017

  Life Sciences Jobs   ...

Athera Biotechnologies Concludes Follow-Up Visits In Multiple Dosing Trial With Its Immunovascular Antibody

  Life Sciences Jobs   ...

ALPCO to Highlight Assay Qualification Program at the AACC’s 69th Annual Scientific Meeting and Clinical Lab Expo

Salem, NH, July 25, 2017 --(PR.com)-- ALPCO, a leading producer of research and clinical immunoassays, announced it will feature a variety of products supported by its assay qualification program at ...

Athera raises SEK57M

Athera begins Phase IIa trial of PC-mAb for arterial inflammation

Drugs and Medications [0 Results]

None

PubMed Articles [13 Associated PubMed Articles listed on BioPortfolio]

Ethical principles for the use of human cellular biotechnologies.

Is De-extinction Special?

I have been involved with the current interest in de-extinction since early 2012, nearly its beginning. I have given a lot of thought to the potential risks and benefits of de-extinction. But only rec...

Overcoming the energetic limitations of syngas fermentation.

The fermentation of synthesis gas (including carbon monoxide, carbon dioxide, and hydrogen) with anaerobic acetogens is an established biotechnological process that has recently been transferred to a ...

'You are inferior!' Revisiting the expressivist argument.

According to the expressivist argument the choice to use biotechnologies to prevent the birth of individuals with specific disabilities is an expression of disvalue for existing people with this disab...

Electricity production and microbial characterization of thermophilic microbial fuel cells.

Thermophilic microbial fuel cell (TMFC) offers many benefits, but the investigations on the diversity of exoelectrogenic bacteria are scarce. In this study, a two-chamber TMFC was constructed using et...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human Stool

The ALPCO Calprotectin ELISA is an in vitro diagnostic test intended to quantitatively measure concentrations of fecal calprotectin in human stool samples. Calprotectin is a protein biomar...

Companies [104 Associated Companies listed on BioPortfolio]

Athera Biotechnologies & ALPCO

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two b...

Athera Biotechnologies AB

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two b...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

ALPCO

ALPCO Diagnostics

More Information about "Athera Biotechnologies & ALPCO" on BioPortfolio

We have published hundreds of Athera Biotechnologies & ALPCO news stories on BioPortfolio along with dozens of Athera Biotechnologies & ALPCO Clinical Trials and PubMed Articles about Athera Biotechnologies & ALPCO for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Athera Biotechnologies & ALPCO Companies in our database. You can also find out about relevant Athera Biotechnologies & ALPCO Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...


Corporate Database Quicklinks



Searches Linking to this Company Record